Literature DB >> 16231093

Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease.

C D Harris1, G Ermak, K J A Davies.   

Abstract

The DSCR1 (Adapt78) gene is transiently induced by stresses to temporarily protect cells against further potentially lethal challenges. However, chronic expression of the DSCR1 (Adapt78) gene has now been implicated in several pathological conditions including Alzheimer's disease, Down syndrome and cardiac hypertrophy. Calcipressin 1 has been shown to function through direct binding and inhibition of the serine threonine protein phosphatase Calcineurin. Pharmacological inhibition of calcineurin, by the immunosuppressive drugs cyclosporin A and FK506, affects a wide variety of diseases. It is, therefore, likely that this endogenous calcineurin inhibitor, calcipressin 1, may also play a role in a variety of human diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231093     DOI: 10.1007/s00018-005-5085-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  43 in total

1.  Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells.

Authors:  Gennady Ermak; Sonal Sojitra; Fei Yin; Enrique Cadenas; Ana Maria Cuervo; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

Review 2.  The Proteasome and Oxidative Stress in Alzheimer's Disease.

Authors:  Vicent Bonet-Costa; Laura Corrales-Diaz Pomatto; Kelvin J A Davies
Journal:  Antioxid Redox Signal       Date:  2016-08-25       Impact factor: 8.401

Review 3.  Calcineurin regulation in fungi and beyond.

Authors:  Jamal Stie; Deborah Fox
Journal:  Eukaryot Cell       Date:  2007-12-07

4.  Down syndrome critical region 1 enhances the proteolytic cleavage of calcineurin.

Authors:  Ji-Eun Lee; Hyonchol Jang; Eun-Jung Cho; Hong-Duk Youn
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

5.  Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.

Authors:  Eun Hye Lee; Seon Sook Kim; Seul Lee; Kwan-Hyuck Baek; Su Ryeon Seo
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

6.  Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.

Authors:  Ramesh N Reddy; Juan A Pena; Brian R Roberts; Stephen R Williams; S Russ Price; Jennifer L Gooch
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

7.  Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.

Authors:  Yue Xu; Boyu Yang; Yaguang Hu; Lin Lu; Xi Lu; Jiawei Wang; Qinmeng Shu; Qiaochu Cheng; Shanshan Yu; Fan Xu; Jingjing Huang; Xiaoling Liang
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

8.  Knockdown of RCAN1.4 Increases Susceptibility to FAS-mediated and DNA-damage-induced Apoptosis by Upregulation of p53 Expression.

Authors:  Young Sun Kim; Hong Joon Lee; Chorong Jang; Ho-Shik Kim; Young-Jin Cho
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

9.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

10.  Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.

Authors:  Yasuko Hirakawa; Laura J Nary; Rheem D Medh
Journal:  J Mol Signal       Date:  2009-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.